Nath Bio-Genes (India) Ltd (NATHBIOGEN) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Prime Fresh

Indo US Bio-Tech

Tierra Agrotech

Halder Venture

Nath Bio-Genes

Sayaji Industr

Pajson Agro

Aelea Commoditi.

BharatRohan Air.

Sawaliya Food

Shivashrit Foods

Why is Nath Bio-Genes (India) Ltd ?

Weak Long Term Fundamental Strength with a -0.21% CAGR growth in Operating Profits over the last 5 years

The company has been able to generate a Return on Equity (avg) of 6.31% signifying low profitability per unit of shareholders funds

Flat results in Sep 25

INTEREST(Latest six months) At Rs 6.86 cr has Grown at 30.17%
PAT(Q) At Rs 0.93 cr has Fallen at -16.1%
CASH AND CASH EQUIVALENTS(HY) Lowest at Rs 0.74 cr

Falling Participation by Institutional Investors

Institutional investors have decreased their stake by -0.76% over the previous quarter and collectively hold 0.32% of the company
These investors have better capability and resources to analyse fundamentals of companies than most retail investors

Below par performance in long term as well as near term

Along with generating -11.91% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Other Agricultural Products)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Nath Bio-Genes for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Nath Bio-Genes

-11.91%

-0.32

37.74%

Sensex

7.18%

0.64

11.21%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

12.65%

EBIT Growth (5y)

-0.21%

EBIT to Interest (avg)

4.76

Debt to EBITDA (avg)

2.39

Net Debt to Equity (avg)

0.23

Sales to Capital Employed (avg)

0.47

Tax Ratio

6.57%

Dividend Payout Ratio

9.59%

Pledged Shares

13.78%

Institutional Holding

0.32%

ROCE (avg)

6.76%

ROE (avg)

6.31%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.41

EV to EBIT

8.83

EV to EBITDA

8.14

EV to Capital Employed

0.52

EV to Sales

1.03

PEG Ratio

1.87

Dividend Yield

1.38%

ROCE (Latest)

5.84%

ROE (Latest)

6.23%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company

NET SALES(Q)

At Rs 65.96 cr has Grown at 78.90%

PAT(9M)

Higher at Rs 40.14 Cr

-14What is not working for the Company

PBT LESS OI(Q)

At Rs -1.95 cr has Fallen at -158.91%

PAT(Q)

At Rs -0.15 cr has Fallen at -105.5%

CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 0.74 cr

DEBT-EQUITY RATIO(HY)

Highest at 0.23 times

INTEREST(Q)

Highest at Rs 4.54 cr

Loading Valuation Snapshot...

Here's what is working for Nath Bio-Genes

Net Sales - Quarterly

At Rs 65.96 cr has Grown at 78.90%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very positive

Net Sales (Rs Cr)

Here's what is not working for Nath Bio-Genes

Profit Before Tax less Other Income (PBT) - Quarterly

At Rs -1.95 cr has Fallen at -158.91%

Year on Year (YoY)

MOJO Watch

Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly

At Rs -0.15 cr has Fallen at -105.5%

Year on Year (YoY)

MOJO Watch

Near term PAT trend is very negative

PAT (Rs Cr)

Interest - Quarterly

Highest at Rs 4.54 cr

in the last five quarters and Increased by 24.04 % (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Cash and Cash Equivalents - Half Yearly

Lowest at Rs 0.74 cr

in the last six half yearly periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio - Half Yearly

Highest at 0.23 times

in the last five half yearly periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio